DCOY
DCOY
NASDAQ · Biotechnology

Decoy Therapeutics Inc

$4.52
-0.30 (-6.22%)
As of May 16, 2:34 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +885.2% upside
Low Target $37.12
Average Target $44.53
High Target $63.68
Current Price $4.52
Current
$4.52
Target
$44.53
$37.12 $44.53 avg $63.68
Scenario Analysis
Bear Case
$37.12
721.2%
Low target
Base Case
$44.53
+885.2%
Avg target
Bull Case
$63.68
+1,308.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$415.80
-98.9% from high
52-Week Low
$4.52
+0.0% from low
Target vs 52W High
$44.53
-89.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%